These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8145852)

  • 1. Specificity of the thrombin receptor for agonist peptide is defined by its extracellular surface.
    Gerszten RE; Chen J; Ishii M; Ishii K; Wang L; Nanevicz T; Turck CW; Vu TK; Coughlin SR
    Nature; 1994 Apr; 368(6472):648-51. PubMed ID: 8145852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasmin desensitization of the PAR1 thrombin receptor: kinetics, sites of truncation, and implications for thrombolytic therapy.
    Kuliopulos A; Covic L; Seeley SK; Sheridan PJ; Helin J; Costello CE
    Biochemistry; 1999 Apr; 38(14):4572-85. PubMed ID: 10194379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protease-activated receptor-1 can mediate responses to SFLLRN in thrombin-desensitized cells: evidence for a novel mechanism for preventing or terminating signaling by PAR1's tethered ligand.
    Hammes SR; Coughlin SR
    Biochemistry; 1999 Feb; 38(8):2486-93. PubMed ID: 10029543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ligand affinity for amino-terminal and juxtamembrane domains of the corticotropin releasing factor type I receptor: regulation by G-protein and nonpeptide antagonists.
    Hoare SR; Sullivan SK; Schwarz DA; Ling N; Vale WW; Crowe PD; Grigoriadis DE
    Biochemistry; 2004 Apr; 43(13):3996-4011. PubMed ID: 15049707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombin receptor activation. Confirmation of the intramolecular tethered liganding hypothesis and discovery of an alternative intermolecular liganding mode.
    Chen J; Ishii M; Wang L; Ishii K; Coughlin SR
    J Biol Chem; 1994 Jun; 269(23):16041-5. PubMed ID: 8206902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands.
    Wilczynski A; Wang XS; Joseph CG; Xiang Z; Bauzo RM; Scott JW; Sorensen NB; Shaw AM; Millard WJ; Richards NG; Haskell-Luevano C
    J Med Chem; 2004 Apr; 47(9):2194-207. PubMed ID: 15084118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protease-activated receptor-2 (PAR-2): structure-function study of receptor activation by diverse peptides related to tethered-ligand epitopes.
    Maryanoff BE; Santulli RJ; McComsey DF; Hoekstra WJ; Hoey K; Smith CE; Addo M; Darrow AL; Andrade-Gordon P
    Arch Biochem Biophys; 2001 Feb; 386(2):195-204. PubMed ID: 11368342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteinase-activated receptors: structural requirements for activity, receptor cross-reactivity, and receptor selectivity of receptor-activating peptides.
    Hollenberg MD; Saifeddine M; al-Ani B; Kawabata A
    Can J Physiol Pharmacol; 1997 Jul; 75(7):832-41. PubMed ID: 9315351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agonist recognition by proteinase-activated receptor 2 and thrombin receptor. Importance of extracellular loop interactions for receptor function.
    Lerner DJ; Chen M; Tram T; Coughlin SR
    J Biol Chem; 1996 Jun; 271(24):13943-7. PubMed ID: 8662993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombin receptor activating mutations. Alteration of an extracellular agonist recognition domain causes constitutive signaling.
    Nanevicz T; Wang L; Chen M; Ishii M; Coughlin SR
    J Biol Chem; 1996 Jan; 271(2):702-6. PubMed ID: 8557676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of thrombin receptor agonist specificity. Chimeric receptors and complementary mutations identify an agonist recognition site.
    Nanevicz T; Ishii M; Wang L; Chen M; Chen J; Turck CW; Cohen FE; Coughlin SR
    J Biol Chem; 1995 Sep; 270(37):21619-25. PubMed ID: 7665575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mapping the interaction of bradykinin 1-5 with the exodomain of human protease activated receptor 4.
    Nieman MT; Pagan-Ramos E; Warnock M; Krijanovski Y; Hasan AA; Schmaier AH
    FEBS Lett; 2005 Jan; 579(1):25-9. PubMed ID: 15620686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential roles of two consecutive phenylalanine residues in thrombin receptor-tethered ligand peptides (SFFLRNP) in thrombin receptor activation.
    Shimohigashi Y; Nose T; Okazaki M; Satoh Y; Ohno M; Costa T; Shimizu N; Ogino Y
    Biochem Biophys Res Commun; 1994 Aug; 203(1):366-72. PubMed ID: 8074680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circular permutation of the granulocyte colony-stimulating factor receptor agonist domain of myelopoietin.
    McWherter CA; Feng Y; Zurfluh LL; Klein BK; Baganoff MP; Polazzi JO; Hood WF; Paik K; Abegg AL; Grabbe ES; Shieh JJ; Donnelly AM; McKearn JP
    Biochemistry; 1999 Apr; 38(14):4564-71. PubMed ID: 10194378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solution structure of the C-terminal SH2 domain of the p85 alpha regulatory subunit of phosphoinositide 3-kinase.
    Siegal G; Davis B; Kristensen SM; Sankar A; Linacre J; Stein RC; Panayotou G; Waterfield MD; Driscoll PC
    J Mol Biol; 1998 Feb; 276(2):461-78. PubMed ID: 9512716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tethered ligand library for discovery of peptide agonists.
    Chen J; Bernstein HS; Chen M; Wang L; Ishii M; Turck CW; Coughlin SR
    J Biol Chem; 1995 Oct; 270(40):23398-401. PubMed ID: 7559498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Domains determining ligand specificity for Ca2+ receptors.
    Hammerland LG; Krapcho KJ; Garrett JE; Alasti N; Hung BC; Simin RT; Levinthal C; Nemeth EF; Fuller FH
    Mol Pharmacol; 1999 Apr; 55(4):642-8. PubMed ID: 10101021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of critical extracellular loop residues involved in alpha 1-adrenergic receptor subtype-selective antagonist binding.
    Zhao MM; Hwa J; Perez DM
    Mol Pharmacol; 1996 Nov; 50(5):1118-26. PubMed ID: 8913343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombin receptor activation by thrombin and receptor-derived peptides in platelet and CHRF-288 cell membranes: receptor-stimulated GTPase and evaluation of agonists and partial agonists.
    Seiler SM; Peluso M; Tuttle JG; Pryor K; Klimas C; Matsueda GR; Bernatowicz MS
    Mol Pharmacol; 1996 Jan; 49(1):190-7. PubMed ID: 8569706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombin receptor agonist peptide induction of mitogenesis in CCL39 cells.
    Reilly CF; Connolly TM; Feng DM; Nutt RF; Mayer EJ
    Biochem Biophys Res Commun; 1993 Feb; 190(3):1001-8. PubMed ID: 8382482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.